Ann: Notification of Investor Webinar - NanaBis Phase III Trial, page-2

Medlab CEO Dr Sean Hall said, “The published clinical trial protocol marks another step towards initiation of the trial, which will commence later this year. We invite interested parties to participate in the webinar for an overview of the study design and endpoints, and to illustrate why Medlab is one of the most advanced medicinal cannabis candidates for the treatment of pain, pursuing an FDA regulatory pathway.”

And MDC remains a whopping $75 million dollar less value than MXC which has zero patents..... good heaven's. MDC=$86mill, MXC=$160mill.